Mardi Gomberg-Maitland, MD, MSc

Dr. Mardi Gomberg-Maitland is a distinguished figure in the realm of cardiovascular and pulmonary medicine, with a particular expertise in pulmonary hypertension (PH).Dr. Gomberg-Maitland's research is notably focused on the epidemiology of pulmonary hypertension, imaging the right ventricle, understanding PH associated with left heart disease and chronic thromboembolic disease and the development and evaluation of novel pharmacological therapies for PAH. She has been instrumental in conducting numerous clinical trials that explore the efficacy and safety of new drugs, aiming to expand the therapeutic options available to patients. Her contributions have led to the approval of several new medications that have improved survival rates and quality of life for PAH patients. Additionally, her research has delved into the genetic and molecular mechanisms underlying PAH, offering insights that have fueled further innovations in targeted treatments.